We evaluated whether evidence for a causal effect of gene expression on CRC risk from our MR and colocalisation analyses were specific to CD4+ T cells or whether the eQTLs used as genetic proxies may also instrument gene expression in other tissues. The gene discussed is CD4; the disease is colorectal carcinoma.